首页> 美国卫生研究院文献>Molecular Therapy >AAV Vectors Containing rDNA Homology Display Increased Chromosomal Integration and Transgene Persistence
【2h】

AAV Vectors Containing rDNA Homology Display Increased Chromosomal Integration and Transgene Persistence

机译:包含rDNA同源性的AAV载体显示增加的染色体整合和转基因持久性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although recombinant adeno-associated viral (rAAV) vectors are promising tools for gene therapy of genetic disorders, they remain mostly episomal and hence are lost during cell replication. For this reason, rAAV vectors capable of chromosomal integration would be desirable. Ribosomal DNA (rDNA) repeat sequences are overrepresented during random integration of rAAV. We therefore sought to enhance AAV integration frequency by including 28S rDNA homology arms into our vector design. A vector containing ~1 kb of homology on each side of a cDNA expression cassette for human fumarylacetoacetate hydrolase (FAH) was constructed. rAAV of serotypes 2 and 8 were injected into Fah-deficient mice, a model for human tyrosinemia type 1. Integrated FAH transgenes are positively selected in this model and rDNA-containing AAV vectors had a ~30× higher integration frequency than controls. Integration by homologous recombination (HR) into the 28S rDNA locus was seen in multiple tissues. Furthermore, rDNA-containing AAV vectors for human factor IX (hFIX) demonstrated increased transgene persistence after liver regeneration. We conclude that rDNA containing AAV vectors may be superior to conventional vector design for the treatment of genetic diseases, especially those associated with increased hepatocyte replication.
机译:尽管重组腺相关病毒(rAAV)载体是用于遗传疾病基因治疗的有前途的工具,但它们仍然大部分是附加型的,因此在细胞复制过程中会丢失。由于这个原因,希望能够进行染色体整合的rAAV载体。核糖体DNA(rDNA)重复序列在rAAV的随机整合过程中被过度代表。因此,我们试图通过将28S rDNA同源臂纳入我们的载体设计来提高AAV整合频率。构建了在人类富马酰乙酰乙酸水解酶(FAH)的cDNA表达盒两侧各具有〜1 kb同源性的载体。将血清型2和8的rAAV注射到人类1型酪氨酸血症模型Fah缺陷型小鼠中,在该模型中阳性选择了整合的FAH转基因,含rDNA的AAV载体的整合频率比对照高约30倍。在多个组织中观察到通过同源重组(HR)整合到28S rDNA基因座中。此外,人肝因子IX(hFIX)的含rDNA的AAV载体在肝再生后表现出提高的转基因持久性。我们得出的结论是,含有rDNA的AAV载体在遗传疾病,尤其是与肝细胞复制增加相关的遗传疾病的治疗中可能优于常规载体设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号